Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan.
Thornton SJ, Wasan KM, Piecuch A, Lynd LL, Wasan EK. Thornton SJ, et al. Among authors: wasan km, wasan ek. Drug Dev Ind Pharm. 2010 Nov;36(11):1312-9. doi: 10.3109/03639041003796648. Drug Dev Ind Pharm. 2010. PMID: 20545513 Review.
Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.
Wasan KM, Wasan EK, Gershkovich P, Zhu X, Tidwell RR, Werbovetz KA, Clement JG, Thornton SJ. Wasan KM, et al. Among authors: wasan ek. J Infect Dis. 2009 Aug 1;200(3):357-60. doi: 10.1086/600105. J Infect Dis. 2009. PMID: 19545212
Visceral leishmaniasis affects liver and spleen concentrations of amphotericin B following administration to mice.
Gershkovich P, Wasan EK, Sivak O, Li R, Zhu X, Werbovetz KA, Tidwell RR, Clement JG, Thornton SJ, Wasan KM. Gershkovich P, et al. Among authors: wasan km, wasan ek. J Antimicrob Chemother. 2010 Mar;65(3):535-7. doi: 10.1093/jac/dkp465. Epub 2009 Dec 21. J Antimicrob Chemother. 2010. PMID: 20026611
A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral Leishmaniasis in a murine model.
Wasan EK, Gershkovich P, Zhao J, Zhu X, Werbovetz K, Tidwell RR, Clement JG, Thornton SJ, Wasan KM. Wasan EK, et al. Among authors: wasan km. PLoS Negl Trop Dis. 2010 Dec 7;4(12):e913. doi: 10.1371/journal.pntd.0000913. PLoS Negl Trop Dis. 2010. PMID: 21151883 Free PMC article.
Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model.
Sivak O, Gershkovich P, Lin M, Wasan EK, Zhao J, Owen D, Clement JG, Wasan KM. Sivak O, et al. Among authors: wasan km, wasan ek. Lipids Health Dis. 2011 Aug 8;10:135. doi: 10.1186/1476-511X-10-135. Lipids Health Dis. 2011. PMID: 21824435 Free PMC article.
Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats.
Ibrahim F, Gershkovich P, Sivak O, Wasan EK, Wasan KM. Ibrahim F, et al. Among authors: wasan km, wasan ek. Drug Dev Ind Pharm. 2013 Sep;39(9):1277-83. doi: 10.3109/03639045.2012.719908. Epub 2012 Sep 18. Drug Dev Ind Pharm. 2013. PMID: 22989082
Novel oral amphotericin B formulation (iCo-010) remains highly effective against murine systemic candidiasis following exposure to tropical temperature.
Wasan KM, Sivak O, Bartlett K, Wasan EK, Gershkovich P. Wasan KM, et al. Among authors: wasan ek. Drug Dev Ind Pharm. 2015;41(9):1425-30. doi: 10.3109/03639045.2014.954587. Epub 2015 Jul 21. Drug Dev Ind Pharm. 2015. PMID: 25170660
Review and analysis of FDA approved drugs using lipid-based formulations.
Savla R, Browne J, Plassat V, Wasan KM, Wasan EK. Savla R, et al. Among authors: wasan ek. Drug Dev Ind Pharm. 2017 Nov;43(11):1743-1758. doi: 10.1080/03639045.2017.1342654. Epub 2017 Jul 6. Drug Dev Ind Pharm. 2017. PMID: 28673096
Scavenger receptor class BI (SR-BI) mediates uptake of CPX-351 into K562 leukemia cells.
Di Y, Wasan EK, Cawthray J, Wasan KM. Di Y, et al. Among authors: wasan ek. Drug Dev Ind Pharm. 2019 Jan;45(1):21-26. doi: 10.1080/03639045.2018.1513026. Epub 2018 Sep 5. Drug Dev Ind Pharm. 2019. PMID: 30113235
Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil.
Mohammed M, Mansell H, Shoker A, Wasan KM, Wasan EK. Mohammed M, et al. Among authors: wasan ek. Drug Dev Ind Pharm. 2019 Jan;45(1):76-87. doi: 10.1080/03639045.2018.1518455. Epub 2018 Sep 25. Drug Dev Ind Pharm. 2019. PMID: 30169982
36 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback